Rongkui Luo

1.5k total citations
83 papers, 713 citations indexed

About

Rongkui Luo is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Rongkui Luo has authored 83 papers receiving a total of 713 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Pulmonary and Respiratory Medicine, 27 papers in Oncology and 23 papers in Surgery. Recurrent topics in Rongkui Luo's work include Sarcoma Diagnosis and Treatment (9 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers) and Neuroendocrine Tumor Research Advances (7 papers). Rongkui Luo is often cited by papers focused on Sarcoma Diagnosis and Treatment (9 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers) and Neuroendocrine Tumor Research Advances (7 papers). Rongkui Luo collaborates with scholars based in China, United States and Singapore. Rongkui Luo's co-authors include Yingyong Hou, Yuan Ji, Kai Zhu, Shengxiang Rao, Kanhua Yin, Zhiqi Zhang, Wentao Wang, Li Yang, Chunlai Lu and Ying Ding and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and Cancer Research.

In The Last Decade

Rongkui Luo

75 papers receiving 708 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rongkui Luo China 14 227 187 169 133 108 83 713
Alejandra Negro United States 12 226 1.0× 121 0.6× 492 2.9× 145 1.1× 82 0.8× 34 863
George Zogopoulos Canada 19 182 0.8× 268 1.4× 557 3.3× 232 1.7× 34 0.3× 54 975
Claudio De Vito Switzerland 15 203 0.9× 358 1.9× 158 0.9× 184 1.4× 25 0.2× 42 824
Francesca Simionato Italy 17 199 0.9× 290 1.6× 455 2.7× 125 0.9× 86 0.8× 31 794
Nadine Arnold United Kingdom 14 413 1.8× 201 1.1× 48 0.3× 212 1.6× 212 2.0× 23 703
Yun–Jie Gao China 20 313 1.4× 200 1.1× 175 1.0× 544 4.1× 30 0.3× 48 1.1k
Geoffrey M. Schultz United States 10 357 1.6× 251 1.3× 285 1.7× 259 1.9× 178 1.6× 13 1.1k
Tiziano Camacci Italy 14 241 1.1× 264 1.4× 276 1.6× 113 0.8× 75 0.7× 18 814
William O’Connor United States 11 139 0.6× 621 3.3× 303 1.8× 169 1.3× 130 1.2× 28 998

Countries citing papers authored by Rongkui Luo

Since Specialization
Citations

This map shows the geographic impact of Rongkui Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rongkui Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rongkui Luo more than expected).

Fields of papers citing papers by Rongkui Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rongkui Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rongkui Luo. The network helps show where Rongkui Luo may publish in the future.

Co-authorship network of co-authors of Rongkui Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Rongkui Luo. A scholar is included among the top collaborators of Rongkui Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rongkui Luo. Rongkui Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Gao, Yuan, Lili Lu, Zhi Pang, et al.. (2025). CD103+CD8+ tissue‐resident memory T lymphocytes of melanoma boost anti‐tumour immunity and predict immunotherapy outcomes. Clinical and Translational Medicine. 15(9). e70464–e70464.
4.
5.
Luo, Rongkui, Lingli Chen, Huimei Wang, et al.. (2025). CPZ. The American Journal of Surgical Pathology. 49(7). 711–729. 1 indexed citations
6.
Liu, Xiaoli, Rongkui Luo, Zhe Jian, et al.. (2025). USP38 functions as an oncoprotein by downregulating the p53 pathway through deubiquitination and stabilization of MDM2. Cell Death and Differentiation. 32(6). 1128–1141. 2 indexed citations
7.
Yang, Shuo, et al.. (2024). Amlodipine inhibits Synaptotagmin-4’s oncogenic activity on gastric cancer proliferation by targeting calcium signaling. Functional & Integrative Genomics. 24(3). 77–77. 4 indexed citations
8.
Ding, Guangyu, Weimin Tan, Youpei Lin, et al.. (2024). Mining the interpretable prognostic features from pathological image of intrahepatic cholangiocarcinoma using multi-modal deep learning. BMC Medicine. 22(1). 282–282. 9 indexed citations
9.
Min, Lingqiang, Bo Zhou, Peng Zhou, et al.. (2024). Transarterial Infusion Chemotherapy and Embolization for Patients With Unresectable Advanced Cancer of Stomach or Gastroesophageal Junction: A Retrospective Study. Cancer Medicine. 13(21). e70396–e70396. 1 indexed citations
10.
Luo, Rongkui, Wen Huang, Wei Yuan, et al.. (2024). IKZF3 amplification predicts worse prognosis especially in intestinal-type gastric cancer. Journal of Cancer Research and Clinical Oncology. 150(7). 363–363. 1 indexed citations
11.
Hang, Xiang, Rongkui Luo, Yunzhi Wang, et al.. (2024). Proteogenomic insights into the biology and treatment of pan-melanoma. Cell Discovery. 10(1). 78–78. 3 indexed citations
12.
Zhao, Yingying, Jiali Qian, Hanxing Tong, et al.. (2024). TRPV4 drives the progression of leiomyosarcoma by promoting ECM1 generation and co-activating the FAK/PI3K/AKT/GSK3β pathway. Cellular Oncology. 48(2). 455–470. 1 indexed citations
13.
Yang, Ziang, Bei Xu, Sheng Wu, et al.. (2022). Exosomal microRNA-551b-3p from bone marrow-derived mesenchymal stromal cells inhibits breast cancer progression via regulating TRIM31/Akt signaling. Human Cell. 35(6). 1797–1812. 9 indexed citations
14.
15.
Zhuang, Rongyuan, Xi Guo, Yang You, et al.. (2022). Anlotinib plus Epirubicin Followed by Anlotinib Maintenance as First-line Treatment for Advanced Soft-tissue Sarcoma: An Open-label, Single-arm, Phase II Trial. Clinical Cancer Research. 28(24). 5290–5296. 11 indexed citations
16.
Xu, Chen, Miaomiao Sun, Hongfang Jin, et al.. (2022). Dual block HER2 assessment increased HER2 immunohistochemistry positive rate in resected specimens of gastric cancer: a prospective multicenter clinical trial from China. Diagnostic Pathology. 17(1). 54–54. 4 indexed citations
17.
Liang, Liang, Rongkui Luo, Ying Ding, et al.. (2020). S100A4 overexpression in pancreatic ductal adenocarcinoma: imaging biomarkers from whole-tumor evaluation with MRI and texture analysis. Abdominal Radiology. 46(2). 623–635. 5 indexed citations
18.
Wang, Jie, Xiaobo Bo, Changcheng Wang, et al.. (2019). Low immune index correlates with favorable prognosis but with reduced benefit from chemotherapy in gallbladder cancer. Cancer Science. 111(1). 219–228. 12 indexed citations
19.
Lin, Yi, Kanhua Yin, Yulin Wang, et al.. (2018). Clinical characteristics and surgical outcomes of dysfunctional quadricuspid aortic valve. Journal of Surgical Research. 229. 223–229. 4 indexed citations
20.
Luo, Rongkui, et al.. (2016). [Hepatic angiomyolipoma: a clinicopathologic features and prognosis analysis of 182 cases].. PubMed. 45(3). 165–9. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alejandra Negro Breakdown of academic impact, for papers by George Zogopoulos Breakdown of academic impact, for papers by Claudio De Vito Breakdown of academic impact, for papers by Francesca Simionato Breakdown of academic impact, for papers by Nadine Arnold Breakdown of academic impact, for papers by Yun–Jie Gao Breakdown of academic impact, for papers by Geoffrey M. Schultz Breakdown of academic impact, for papers by Tiziano Camacci Breakdown of academic impact, for papers by William O’Connor
Rankless by CCL
2026